Cora Capital Advisors’s Merck MRK Stock Holding History

Cora Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$598K	Buy	4,970 +96	+2%	+$11.1K	0.2%	62
2025 Q4	$513K	Buy	4,874 +241	+5%	+$22.6K	0.2%	65
2025 Q3	$389K	Sell	4,633 -710	-13%	-$58.5K	0.17%	68
2025 Q2	$423K	Buy	5,343 +125	+2%	+$9.94K	0.19%	63
2025 Q1	$468K	Buy	5,218 +65	+1%	+$6.07K	0.22%	65
2024 Q4	$513K	Buy	5,153 +42	+0.8%	+$4.33K	0.25%	61
2024 Q3	$580K	Sell	5,111 -4	-0.1%	-$475	0.29%	56
2024 Q2	$633K	Buy	5,115 +17	+0.3%	+$2.19K	0.33%	51
2024 Q1	$673K	Buy	5,098 +27	+0.5%	+$3.33K	0.36%	50
2023 Q4	$553K	Buy	5,071 +240	+5%	+$24.9K	0.33%	53
2023 Q3	$497K	Buy	4,831 +92	+2%	+$9.92K	0.33%	52
2023 Q2	$547K	Buy	4,739 +371	+8%	+$42.1K	0.36%	52
2023 Q1	$465K	Buy	4,368 +90	+2%	+$9.72K	0.35%	48
2022 Q4	$475K	Buy	+4,278	New	+$437K	0.33%	46

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cora Capital Advisors's MRK Position: Q1 2026 in Review

Cora Capital Advisors increased its Merck (MRK) stake by 2% in Q1 2026, buying an estimated $11.1K and bringing the position to 4,970 shares worth $598K. The position accounts for 0.2% of the portfolio, ranked #62.

Cora Capital Advisors first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $673K in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Cora Capital Advisors held 4,970 shares of Merck worth $598K as of Q1 2026.
Cora Capital Advisors bought 96 Merck shares in Q1 2026, an estimated $11.1K.
Merck made up 0.2% of Cora Capital Advisors's portfolio in Q1 2026, its #62 holding.
Cora Capital Advisors first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
Cora Capital Advisors's Merck position peaked at $673K in Q1 2024.
3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cora Capital Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.